A detailed history of Daiwa Securities Group Inc. transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 245 shares of NRIX stock, worth $6,580. This represents 0.0% of its overall portfolio holdings.

Number of Shares
245
Previous 152 61.18%
Holding current value
$6,580
Previous $3,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$18.93 - $25.69 $1,760 - $2,389
93 Added 61.18%
245 $6,000
Q3 2021

Nov 05, 2021

BUY
$22.71 - $36.69 $1,794 - $2,898
79 Added 108.22%
152 $5,000
Q4 2020

Feb 04, 2021

BUY
$22.85 - $48.44 $1,668 - $3,536
73 New
73 $2,000

Others Institutions Holding NRIX

About Nurix Therapeutics, Inc.


  • Ticker NRIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,147,800
  • Market Cap $1.27B
  • Description
  • Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...
More about NRIX
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.